Entera Bio Ltd. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Kesselman & Kesselman, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 USD | -1.00% | -0.50% | +230.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+230.00% | 70.25M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ENTX Stock
- News Entera Bio Ltd.
- Entera Bio Ltd. Auditor Raises 'Going Concern' Doubt